The Inova Personalized Health Accelerator (IPHA) is dedicated to finding and enabling the next generation of medical technology and healthcare start-ups seeking to enhance patient care, predict and prevent disease, lower healthcare costs, and improve health outcomes. Our goal is to partner with entrepreneurs to bring the most promising healthcare innovations to market. Working closely together, we can quickly achieve significant milestones in value creation and risk mitigation for our partner companies.

1. HOW IS IPHA DIFFERENT?
IPHA redefines the concept of early-stage accelerators by developing an action plan
in consultation with the entrepreneur that is customized to the needs of the medical
technology start-up.
• A team of seasoned C-Suite executives becomes an extension of the existing
management team, to help companies achieve the value-creating milestones that
will improve success and earn investor attention.
• Each participating company will receive bespoke action and risk-mitigation plans.
• $75,000 in cash and a full range of C-Suite services equivalent to a minimum of
$125,000 will be invested in start-ups that are accepted into the IPHA program,
in return for a 10% equity position in the next funding round.
• A matching investment of up to $250,000 will be provided if the company meets
all milestones and receives funding during the program, or up to 12 months after
graduation from the IPHA program.
• The Inova Health System and extended family of health systems and venture funds
are potential customers and additional funding sources for future rounds.
• IPHA has a year-round, rolling application process, limited to a maximum of 6
companies at any time, in order to provide the individual attention that each company/
team deserves.
WHAT TYPES OF COMPANIES QUALIFY?
The IPHA team is looking for nascent technology companies with working prototypes,
who are seeking venture investment for product development and commercialization.
• Pre-Series A and/or Seed stage
• Types of technology focused on personalized health:
- Diagnostics
- Medical devices
- Digital health
- FDA 510(k) class I, II and de novo
regulatory pathways
- Sensor technologies
- A.I./Machine Learning
- Genomics, precision medicine
- Health IT, software, analytics
Candidate companies must be committed to dedicating time to the IPHA program located at the Inova Center for Personalized Health
in Fairfax, VA. (However, companies do not have to relocate.)
application process
WHO CAN APPLY?
IPHA is seeking start-ups that enhance our
mission of advancing personalized health.
WHAT IS IT LIKE TO PARTICIPATE?
IPHA provides office space for the duration
of the program, amenities, a tailored
curriculum, C-suite consultations, an
extensive mentor network, and access to
Northern Virginia’s premier health system.
WHEN CAN I APPLY?
We have a year-round, rolling application
process.
HOW DO I APPLY?
All we require is an application letter and
a video, both of which should be submitted
online at inovapha.org/apply/
WILL INOVA SIGN AN NDA?
Not at this stage.
WHAT IF I HAVE MORE QUESTIONS?
Please review our website at inovapha.org.
If you have additional questions, email us at
info@inovapha.org.
MISSION STATEMENT: The Inova Personalized Health Accelerator (IPHA) is dedicated to finding and enabling the
next generation of medical technology and healthcare start-ups seeking to enhance patient care, predict and prevent
disease, lower healthcare costs, and improve health outcomes. Our goal is to partner with entrepreneurs to bring the
most promising healthcare innovations to market. Working closely together, we can quickly achieve significant milestones
in value creation and risk mitigation for our partner companies.
propelling technology
to point-of-care
WE KNOW HOW TO BUILD YOUR COMPANY
INTO A SUSTAINABLE BUSINESS.

2. Director
Richard.Gordon2@inova.org
RICK GORDON
IPHA IS THE PREMIER ACCELERATOR FOCUSED
ON PERSONALIZED HEALTH START-UPS
IPHA offers an intensive, customized program on the campus of the Inova Center for
Personalized Health (ICPH) in Fairfax, VA. During the program, companies will work closely
with the IPHA team to evolve initial stage prototypes to validated products, mature
business models, and go-to-market plans for their healthcare technology solutions.
The program includes modules in these disciplines:
• Product validation
• Customer acquisition
• Capital planning
• Investor development
• Talent recruitment
• Board development
• Regulatory & quality compliance
• Reimbursement strategies
• Clinical evaluation
WHAT ARE OUR STRENGTHS?
The IPHA team has a documented track record of starting, building, commercializing,
growing, investing in and exiting medical technology companies. We have delivered
superior returns to our investors and strategic partners. We also have extensive
experience in recruiting and mentoring exceptional, impact-oriented management teams.
HOW DO WE DEFINE SUCCESS?
We have a unique view of success. Rather than focusing on completion dates, demo days
and networking events, we believe that early-stage company development requires deep
involvement with prospective customers, investors, regulators and payers. It is this
discipline that will position your company to secure additional capital, to continue your
process of development and value creation.
Ask us about the vested interest our directors have in your success.
WHAT TYPES OF COMPANIES DO NOT QUALIFY FOR IPHA?
• Pharmaceuticals, Biotech
• FDA 510(k) Class III products
• PMA regulatory pathway products
• Invasive therapies
• Roll-ups
• Insurance technologies
ABOUT THE INOVA CENTER FOR PERSONALIZED HEALTH
The Inova Center for Personalized Health (ICPH) is the host facility for the IPHA, in Fairfax,
VA. ICPH is a global leader in the research, development and application of innovative
personalized health therapies that enable individuals to live longer, healthier lives. ICPH is
an extension of Inova Health System’s commitment to leading the way in the integration of
genomics into personalized medicine and individualized wellness.
ABOUT INOVA HEALTH SYSTEM
The five hospitals in the Inova Health System have more than 1,700 beds and encompass
the full array of health services, including a Level 1 Trauma Center and a Level IV Neonatal
Intensive Care Unit. Inova also provides nationally recognized care in heart and vascular
medicine, cancer, and neuroscience, as well as groundbreaking work in genomics and
translational medicine.
inovapha.org/info@inovapha.org
© Copyright 2017 Inova Personalized Health Accelerator BC20170801
IPHA leadership team
Managing Director
peter.jobse@inova.org
PETE JOBSE
Director
michael.thomas4@inova.org
MICHAEL THOMAS
propelling technology
to point-of-care
WE KNOW HOW TO BUILD YOUR COMPANY
INTO A SUSTAINABLE BUSINESS.